1999
DOI: 10.1111/j.1699-0463.1999.tb01524.x
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms for pro matrix metalloproteinase activation

Abstract: for pro matrix metalloproteinase activation. APMIS 1999;107:3844. The activation of pro matrix metalloproteinases (MMPs) by sequential proteolysis of the propeptide blocking the active site cleft is regarded as one of the key levels of regulation of these proteinases. Potential physiological mechanisms including cell-associated plasmin generation by urokinase-like plasminogen activator, or the action of cell surface MTI-MMPs appear to be involved in the initiation of cascades of pro M M P activation. Gelatinas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
328
0
8

Year Published

1999
1999
2012
2012

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 440 publications
(339 citation statements)
references
References 44 publications
3
328
0
8
Order By: Relevance
“…MT1-MMP requires proteolytic activation and the removal of the N-terminal prodomain sequence in order to be converted into the catalytically active species (Murphy et al, 1999). Activation by PCs occurs in the secretory pathway of the de novo synthesized MT1-MMP and this process is tightly linked to the presentation and, consequently, to the activity of cellular MT1-MMP (Seidah and Prat, 2002;Osenkowski et al, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…MT1-MMP requires proteolytic activation and the removal of the N-terminal prodomain sequence in order to be converted into the catalytically active species (Murphy et al, 1999). Activation by PCs occurs in the secretory pathway of the de novo synthesized MT1-MMP and this process is tightly linked to the presentation and, consequently, to the activity of cellular MT1-MMP (Seidah and Prat, 2002;Osenkowski et al, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…Cathepsin B-positive cells often coexpressed HAM56 too, which is a known marker for mononuclear macrophages in GCTTS (2,40). Cathepsin B may be involved in cartilage and bone destruction by degrading proteoglycans, different collagen types (II, IX, and XI), and the bone matrix protein osteocalcin as well as by activating the collagenolytic metalloproteinases interstitial collagenase (MMP-1) and stromelysin (17)(18)(19). The expression of both MMP-1 and MMP-3 has been examined in pigmented villonodular synovitis, which is considered to be a closely related entity of GCTTS.…”
Section: Discussionmentioning
confidence: 99%
“…This mechanism is not fully understood, but involves membrane-type MMPs (MT-MMPs) such as MT1-MMP (MMP-14), the most potent activator of MMP-2 by cleaving the N-terminal domain of ProMMP-2 (Sato et al, 1994;Cao et al, 1995). The endogenous inhibitor of MMP-2, tissue inhibitor of metalloproteinases -2 (TIMP-2) has been shown to inhibit both the activation of MMP-2 and activity of MMP-2 by blocking further cleavage of the proform active site cleft and blocking the catalytic domain of both active MMP-2 and MMP-14 Corcoran et al, 1996;Murphy et al, 1999). Moreover, steady state levels of TIMP-2 mRNA have been shown to decrease in the fibrous sclera of chick eyes which are actively elongating, and increase in the sclera of chick eyes which are slowing their rate of axial elongation, suggesting that TIMP-2 plays a role in the regulation of scleral extracellular matrix remodeling in chick sclera associated with changes in ocular elongation rates (Rada et al, 1999).…”
Section: Introductionmentioning
confidence: 99%